Northern Trust Corp Arbutus Biopharma Corp Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,056,604 shares of ABUS stock, worth $3.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,056,604

Previous 1,068,221 1.09%

Holding current value

$3.31 Million

Previous $2.67 Million 2.1%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.26 - $2.92 $26,254 - $33,921	-11,617 Reduced 1.09%	1,056,604 $2.73 Million
Q4 2023 Feb 13, 2024	BUY	$1.69 - $2.54 $4,814 - $7,236	2,849 Added 0.27%	1,068,221 $2.67 Million
Q3 2023 Nov 13, 2023	BUY	$1.9 - $2.27 $41,630 - $49,737	21,911 Added 2.1%	1,065,372 $2.16 Million
Q2 2023 Aug 11, 2023	BUY	$2.24 - $3.06 $209,599 - $286,327	93,571 Added 9.85%	1,043,461 $2.4 Million
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $69,462 - $96,561	31,149 Added 3.39%	949,890 $2.88 Million

Q4 2022 Feb 13, 2023	BUY	$1.91 - $2.85 $34,750 - $51,852	18,194 Added 2.02%	918,741 $2.14 Million
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $6,721 - $10,296	3,575 Added 0.4%	900,547 $1.72 Million
Q2 2022 Aug 12, 2022	BUY	$1.98 - $3.17 $243,011 - $389,063	122,733 Added 15.85%	896,972 $2.43 Million
Q1 2022 May 13, 2022	BUY	$2.42 - $3.98 $96,245 - $158,288	39,771 Added 5.41%	774,239 $2.31 Million
Q4 2021 Feb 08, 2022	BUY	$3.11 - $4.61 $105,628 - $156,574	33,964 Added 4.85%	734,468 $2.86 Million
Q3 2021 Nov 15, 2021	SELL	$2.65 - $4.62 $49,435 - $86,186	-18,655 Reduced 2.59%	700,504 $3.01 Million
Q2 2021 Aug 13, 2021	BUY	$2.5 - $3.51 $1.47 Million - $2.06 Million	586,456 Added 441.93%	719,159 $2.18 Million
Q1 2021 May 12, 2021	BUY	$3.14 - $4.84 $58,090 - $89,540	18,500 Added 16.2%	132,703 $442,000
Q4 2020 Feb 11, 2021	SELL	$2.76 - $4.97 $15,124 - $27,235	-5,480 Reduced 4.58%	114,203 $405,000
Q3 2020 Nov 16, 2020	BUY	$1.75 - $6.2 $29,568 - $104,755	16,896 Added 16.44%	119,683 $375,000
Q2 2020 Aug 14, 2020	BUY	$0.91 - $2.36 $93,536 - $242,577	102,787 New	102,787 $188,000
Q3 2019 Nov 13, 2019	SELL	$1.34 - $2.4 $392,724 - $703,387	-293,078 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$1.46 - $4.44 $30,195 - $91,828	-20,682 Reduced 6.59%	293,078 $610,000
Q1 2019 May 13, 2019	BUY	$3.41 - $4.57 $9,009 - $12,073	2,642 Added 0.85%	313,760 $1.12 Million
Q4 2018 Feb 12, 2019	SELL	$3.5 - $9.66 $72,065 - $198,899	-20,590 Reduced 6.21%	311,118 $1.19 Million
Q3 2018 Nov 14, 2018	BUY	$7.85 - $12.35 $277,042 - $435,856	35,292 Added 11.91%	331,708 $3.14 Million
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $1.48 Million - $2.18 Million	296,416 New	296,416 $2.16 Million

Others Institutions Holding ABUS

# of Institutions

130

Shares Held

82.2M

Call Options Held

4.82M

Put Options Held

546K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $469M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Arbutus Biopharma Corp Transaction History